APRE
Price
$1.75
Change
-$0.06 (-3.31%)
Updated
Jun 6 closing price
Capitalization
9.68M
ATOS
Price
$0.90
Change
+$0.04 (+4.65%)
Updated
Jun 6 closing price
Capitalization
116.27M
72 days until earnings call
Interact to see
Advertisement

APRE vs ATOS

Header iconAPRE vs ATOS Comparison
Open Charts APRE vs ATOSBanner chart's image
Aprea Therapeutics
Price$1.75
Change-$0.06 (-3.31%)
Volume$24.17K
Capitalization9.68M
Atossa Therapeutics
Price$0.90
Change+$0.04 (+4.65%)
Volume$646.63K
Capitalization116.27M
APRE vs ATOS Comparison Chart
Loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APRE vs. ATOS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Buy and ATOS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (APRE: $1.75 vs. ATOS: $0.90)
Brand notoriety: APRE and ATOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 80% vs. ATOS: 88%
Market capitalization -- APRE: $9.68M vs. ATOS: $116.27M
APRE [@Biotechnology] is valued at $9.68M. ATOS’s [@Biotechnology] market capitalization is $116.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileATOS’s FA Score has 1 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • ATOS’s FA Score: 1 green, 4 red.
According to our system of comparison, APRE is a better buy in the long-term than ATOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 6 TA indicator(s) are bullish while ATOS’s TA Score has 5 bullish TA indicator(s).

  • APRE’s TA Score: 6 bullish, 2 bearish.
  • ATOS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APRE is a better buy in the short-term than ATOS.

Price Growth

APRE (@Biotechnology) experienced а +0.57% price change this week, while ATOS (@Biotechnology) price change was +15.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

APRE is expected to report earnings on Mar 25, 2025.

ATOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($116M) has a higher market cap than APRE($9.68M). ATOS YTD gains are higher at: -4.661 vs. APRE (-46.809). APRE has higher annual earnings (EBITDA): -14.75M vs. ATOS (-29.46M). ATOS has more cash in the bank: 74.8M vs. APRE (26.2M). APRE (0) and ATOS (0) have identical debt. APRE (0) and ATOS (0) have equivalent revenues.
APREATOSAPRE / ATOS
Capitalization9.68M116M8%
EBITDA-14.75M-29.46M50%
Gain YTD-46.809-4.6611,004%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.2M74.8M35%
Total Debt00-
FUNDAMENTALS RATINGS
ATOS: Fundamental Ratings
ATOS
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APREATOS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIGYX34.89N/A
N/A
Invesco Oppenheimer International Gr Y
SLPSX83.23N/A
N/A
ProFunds Small Cap Svc
PXGAX23.16N/A
N/A
Impax US Sustainable Economy A
MSCMX15.73N/A
N/A
Morgan Stanley Insight C
VYSYX10.11N/A
N/A
Voya Small Company A